Skip to content

Clinical evaluation of a new hyaluronic acid filler

Clinical review of 106 cases using a novel crosslinked hyaluronic acid filler

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN79475131
Enrollment
106
Registered
2026-04-30
Start date
2022-01-01
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging or photo-aging related wrinkles and hollows in the face. Other

Interventions

In this open-label, non-randomized study, CE-approved HA-CHDT filler was used to restore facial volume in 106 patients. Thus, both sides (without control) were injected with the same filler. The tre
instead, patients were allocated to one of three HY-HA products: Hyafilia V (HYAV), Hyafilia M (HYAM), or Hyafilia S (HYAS). HYAS was used for shallow defects and superficial wrinkles, HYAM for medium

Sponsors

Dr Aydin Saray Clinic
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Healthy individuals who have not been treated with any filler, energy-based device, or surgery in the whole facial region 2. Without any diagnosed autoimmune disease are included in the study

Exclusion criteria

Exclusion criteria: 1. Infection in the facial zones to be treated 2. Autoimmune disease 3. Previous filler injection 4. Previous facial surgery 5. Previous skin booster injection 6. Pregnancy and lactation 7. Any active viral disease, including herpes virus infection 8. Previous energy-based treatments such as lasers, skin tightening devices, microneedling

Countries

Türkiye

Contacts

Public ContactAydin Saray
info@aydinsaray.com+90 05322725310

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 16, 2026